Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase

Journal of Clinical Investigation

Volumn 111, Issue 2, 2003, Pages 231-239

  Cokic, Vladan P ^a,b   Smith, Reginald D ^a   Beleslin Cokic, Bojana B ^a   Njoroge, Joyce M ^a   Miller, Jeffery L ^a   Gladwin, Mark T ^a,c   Schechter, Alan N ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; CYSTEINE DERIVATIVE; GAMMA GLOBIN; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; MESSENGER RNA; NITRIC OXIDE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA CELL; GENE INDUCTION; HUMAN; HUMAN CELL; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN INDUCTION; SICKLE CELL ANEMIA;

EID: 0037237980     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316672     Document Type: Article

References (51)

1. Charache, S., et al. 1998. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N. Engl. J. Med. 332:1317-1322.
2. Charache, S. 1997. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin. Hematol. 34:15-21.
3. Atweh, G.F., and Schechter, A.N. 2001. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease. Curr. Opin. Hematol. 8:123-130.
4. Letvin, N.L., et al. 1985. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. J. Clin. Invest. 75:1999-2005.
5. Platt, O.S., et al. 1984 Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J. Clin. Invest. 74:652-656.
6. Veith, R., Galanello, R., Papayannopoulou, T., and Stamatoyannopoulos, G. 1985. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N. Engl. J. Med. 313:1571-1575.
7. Stoeckert, C.J., Jr., and Green, M.B. 1994. Erythropoietin and hydroxyurea can act on early erythroid progenitors from adult human peripheral blood to modulate fetal globin mRNA levels. Exp. Hematol. 22:278-282.
8. Fibach, E., Burke, L.P., Schechter, A.N., Noguchi, C.T., and Rodgers, G.P. 1993. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. Blood. 81:1630-1635.
9. Erard, F., Dean, A., and Schechter, A.N. 1981. Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood. 58:1236-1239.
10. Xu, J., and Zimmer, D.B. 1998. Differential regulation of A gamma and G gamma fetal hemoglobin mRNA levels by hydroxyurea and butyrate. Exp. Hematol. 26:265-272.
11. Smith, R.D., Li, J., Noguchi, C.T., and Schechter, A.N. 2000. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. Blood. 95:863-869.
12. Yarbro, J.W., Kennedy, B.J., and Barnum, C.P. 1965. Hydroxyurea inhibition of DNA synthesis in ascires tumor. Proc. Natl. Acad. Sci. USA. 53:1033-1035.
13. Krakoff, I.H., Brown, N.C., and Reichard, P. 1968. Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res. 28:1559-1565.
14. Stolze, K., and Nohl, H. 1990. EPR studies on the oxidation of hydroxyurea to paramagnetic compounds by oxyhemoglobin. Biochem. Pharmacol. 40:799-802.
15. Pacelli, R., Taira, J., Cook, J.A., Wink, D.A., and Krishna, M.C. 1996. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet. 347:900.
16. Kim-Shapiro, D.B., King, S.B., Bonifant, C.L., Kolibash, C.P., and Ballas, S.K. 1998. Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin. Biochim. Biophys. Acta. 1380:64-74.
17. Jiang, J., et al. 1997. In vivo production of nitric oxide in rats after administration of hydroxyurea. Mol. Pharmacol. 52:1081-1086.
18. Glover, R.E., Ivy, E.D., Orringer, E.P., Maeda, H., and Mason, R.P. 1999. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol. Pharmacol. 55:1006-1010.
19. Nahavandi, M., Wyche, M.Q., Perlin, E., Tavakkoli, F., and Castro, O. 2000. Nitric oxide metabolites in sickle cell anemia patients after oral administration of hydroxyurea; hemoglobinopathy. Hematology. 5:335-339.
20. Gladwin, M.T., et al. 2002. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br. J. Haematol. 116:436-444.
21. Lassmann, G., Thelander, L., and Graslund, A. 1992. EPR stopped-flow studies of the reaction of the tyrosyl radical of protein R2 from ribonucleotide reductase with hydroxyurea. Biochem. Biophys. Res. Commun. 188:879-887.
22. Yarbro, J.W. 1992. Mechanism of action of hydroxyurea. Semin. Oncol. 19:1-10.
23. Kwon, N.S., Stuehr, D.J., and Nathan, C.F. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:761-767.
24. Lepoivre, M., Flaman, J.M., Bobe, P., Lemaire, G., and Henry, Y. 1994. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J. Biol. Chem. 269:21891-21897.
25. Bundy, R., Marczin, N., Chester, A.H., and Yacoub, M. 1999. Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells. Am. J. Physiol. 277:H1799-H1807.
26. Ikuta, T., Ausenda, S., and Cappellini, M.D. 2001. Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc. Natl. Acad. Sci. USA. 98:1847-1852.
27. Fibach, E., Manor, D., Oppenheim, A., and Rachmilewitz, E.A. 1989. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood. 73:100-103.
28. Kwan, J.T., Carr, E.C., Bending, M.R., and Barron, J.L. 1990. Determination of carbamylated hemoglobin by high-performance liquid chromatography. Clin. Chem. 36:607-610.
29. Bisse, E., Huaman-Guillen, P., and Wieland, H. 1995. Chromatographic evaluation of minor hemoglobins: clinical significance of hemoglobin A1d, comparison with hemoglobin A1c, and possible interferences. Clin. Chem. 41:658-663.
30. Shami, P.J., and Weinberg, J.B. 1996. Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. Blood. 87:977-982.
31. Yang, Y.M., et al. 1997. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction. Am. J. Hematol. 56:252-258.
32. Ballas, S.K., Marcolina, M.J., Dover, G.J., and Barton, F.B. 1999. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. Br. J. Haematol. 105:491-496.
33. Goldberg, M.A., et al. 1990. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N. Engl. J. Med. 323:366-372.
34. Mankad, V.N., Baliga, S., Phillips, K., Shah, A.K., and Yang, Y.M. 1994. Relationship of burst-forming-unit-erythroid progenitors and their DNA-synthesis stage to fetal hemoglobin levels in hydroxyurea-treated patients with sickle cell anemia. Am. J. Hematol. 46:259-263.
35. Rodgers, G.P., et al. 1993. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N. Engl. J. Med. 328:73-80
36. Charache, S., Dover, G.J., Moyer, M.A., and Moore, J.W. 1987. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood. 69:109-116.
37. Kim-Shapiro, D.B., et al. 1999. The reaction of deoxy-sickle cell hemoglobin with hydroxyurea. Biochim. Biophys. Acta. 1428:381-387.
38. Huang, J., et al. 2002. Iron nitrosyl hemoglobin formation from the reactions of hemoglobin and hydroxyurea. Biochemistry. 41:2466-2474.
39. Denninger, J.W., and Marletta, M.A. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411:334-350.
40. Moi, P., and Kan, Y.W. 1990. Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc. Natl. Acad. Sci. USA. 87:9000-9004
41. Safaya, S., Ibrahim, A., and Rieder, R.F. 1994. Augmentation of gammaglobin gene promoter activity by carboxylic acids and components of the human beta-globin locus control region. Blood. 84:3929-3935.
42. Haby, C., Lisovoski, F., Aunis, D., and Zwiller, J. 1994. Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J. Neurochem. 62:496-501.
43. Idriss, S.D., et al. 1999. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase. J. Biol. Chem. 274:9489-9493.
44. Adunyah, S.E., Chander, R., Barner, V.K., and Cooper, R.S. 1995. Regulation of c-jun mRNA expression by hydroxyurea in human K562 cells during erythroid differentiation. Biochim. Biophys. Acta. 1263:123-132.
45. Browning, D.D., Windes, N.D., and Ye, R.D. 1999. Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J. Biol. Chem. 274:537-542.
46. Browning, D.D., McShane, M.P., Marty, C., and Ye, R.D. 2000. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J. Biol. Chem. 275:2811-2816.
47. Kim, S.O., Xu, Y., Katz, S., and Pelech, S. 2000 Cyclic GMP-dependent and -independent regulation of MAP kinases by sodium nitroprusside in isolated cardiomyocytes. Biochim. Biophys. Acta. 1496:277-284.
48. Chen, K., and Maines, M.D. 2000. Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38. Cell. Mol. Biol. (Noisy-le-grand). 46:609-617.
49. Park, J.I., Choi, H.S., Jeong, J.S., Han, J.Y., and Kim, I.H. 2001. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ. 12:481-486.
50. Fischer, K.D., Haese, A., and Nowock, J. 1993. Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J. Biol. Chem. 268:23915-23923.
51. Wang, S., Wang, W., Wesley, R.A., and Danner, R.L. 1999. A Sp1 binding site of the tumor necrosis factor alpha promoter functions as a nitric oxide response element. J. Biol. Chem. 274:33190-33193.